Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Debt (2017 - 2020)

AC Immune (ACIU) reported Total Debt of $336773.3 for Q3 2020, down 47.41% year-over-year from $640434.3 in Q4 2019, and up 1.09% on a QoQ basis from $333137.6 in Q2 2020.

AC Immune (ACIU) has 4 years of Total Debt data on file, last reported at $336773.3 in Q3 2020.

  • Quarterly Total Debt fell 47.41% year-over-year to $336773.3 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $336773.3 (down 47.41% YoY) and the FY2019 annual result came in at $656409.3, up 26.11% from the prior year.
  • Total Debt grew to $336773.3 in Q3 2020 per ACIU's latest filing, from $333137.6 in the prior quarter.
  • Across five years, Total Debt topped out at $658770.1 in Q4 2019 and bottomed at $583.43 in Q2 2019.
  • The 4-year median for Total Debt is $336773.3 (2020), against an average of $388856.3.
  • Peak annual rise in Total Debt reached 57000.32% in 2020, while the deepest fall reached 47.41% in 2020.
  • Tracing ACIU's Total Debt over 4 years: stood at $500708.2 in 2017, then grew by 3.95% to $520504.4 in 2018, then rose by 26.56% to $658770.1 in 2019, then slumped by 48.88% to $336773.3 in 2020.
  • Per Business Quant, the three latest ACIU Total Debt figures stand at $336773.3 (Q3 2020), $333137.6 (Q2 2020), and $334966.3 (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.99 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 AC Immune 325.88 Mn 211.53 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 336,773.30
Jun 30, 2020 333,137.61
Mar 31, 2020 334,966.30
Dec 31, 2019 658,770.12
Sep 30, 2019 640,434.31
Jun 30, 2019 583.43
Mar 31, 2019 563,279.07
Dec 31, 2018 520,504.42
Dec 31, 2017 500,708.16
Sep 30, 2017 196,427.87
Jun 30, 2017 191,834.75